Chargement en cours...
MicroRNA-218 enhances gastric cancer cell cisplatin sensitivity by targeting survivin
Gastric cancer (GC) is one of the most prevalent types of cancer worldwide. Cisplatin based chemotherapy is the primary strategy implemented for the treatment of G; however, chemoresistance is a major problem. Previous studies have indicated that microRNAs (miRs) are associated with chemoresistance...
Enregistré dans:
| Publié dans: | Exp Ther Med |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6257577/ https://ncbi.nlm.nih.gov/pubmed/30542435 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6802 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|